Gilead reports Q4 earnings on Feb. 11. Analysts expect $1.70 EPS. The LEO Pharma deal could reduce 2025 EPS by up to $0.17.
What To Expect When Biotech Giant Gilead Reports Q4 Earnings On Tuesday?
Where Today's News Shapes Tomorrow
February 25, 2026
Headlines
